000 | 01556 a2200469 4500 | ||
---|---|---|---|
005 | 20250517071111.0 | ||
264 | 0 | _c20161020 | |
008 | 201610s 0 0 eng d | ||
022 | _a2045-7634 | ||
024 | 7 |
_a10.1002/cam4.580 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLin, Peggy L | |
245 | 0 | 0 |
_aPhysician experiences and preferences in the treatment of HR+/HER2- metastatic breast cancer in the United States: a physician survey. _h[electronic resource] |
260 |
_bCancer medicine _cFeb 2016 |
||
300 |
_a209-20 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aBreast Neoplasms _xepidemiology |
650 | 0 | 4 | _aDrug Prescriptions |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aNeoplasm Metastasis |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 | _aPhysicians |
650 | 0 | 4 | _aPostmenopause |
650 | 0 | 4 | _aPractice Patterns, Physicians' |
650 | 0 | 4 |
_aReceptor, ErbB-2 _xmetabolism |
650 | 0 | 4 |
_aReceptors, Estrogen _xmetabolism |
650 | 0 | 4 |
_aReceptors, Progesterone _xmetabolism |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSurveys and Questionnaires |
650 | 0 | 4 |
_aUnited States _xepidemiology |
700 | 1 | _aHao, Yanni | |
700 | 1 | _aXie, Jipan | |
700 | 1 | _aLi, Nanxin | |
700 | 1 | _aZhong, Yichen | |
700 | 1 | _aZhou, Zhou | |
700 | 1 | _aSignorovitch, James E | |
700 | 1 | _aWu, Eric Q | |
773 | 0 |
_tCancer medicine _gvol. 5 _gno. 2 _gp. 209-20 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/cam4.580 _zAvailable from publisher's website |
999 |
_c25559246 _d25559246 |